Alnylam Pharmaceuticals, Inc.;ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
发明人:
BETTENCOURT, Brian,FITZGERALD, Kevin,QUERBES, William,YASUDA, Makiko,DESNICK, Robert J.
申请号：
AU2018203098
公开号：
AU2018203098A1
申请日:
2018.05.03
申请国别(地区):
AU
年份:
2018
代理人:
摘要：
#$%^&*AU2018203098A120180524.pdf#####Abstract The invention relates to double-stranded ribonucleic acid (dsRNA) compositions targeting the ALASI gene, and methods 5 of using such dsRNA compositions to alter (e.g., inhibit) expression of ALASI. W: NRPortbl GHMatters MICHELES 10234591_1.docx 3/05/18
